Cargando…
2571. Posaconazole DRT in Children; Time to Bring Out the Pill Crusher?
BACKGROUND: Posaconazole, a broad-spectrum triazole antifungal, is licenced for prophylaxis and treatment of invasive fungal infections (IFI). Young children who are unable to swallow tablets or those with enteral tubes are routinely prescribed oral suspension. However, this formulation has poor bio...
Autores principales: | Weerdenburg, Heather L, Gwee, Amanda, Haeusler, Gabrielle, Osowicki, Joshua, Boast, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678372/ http://dx.doi.org/10.1093/ofid/ofad500.2188 |
Ejemplares similares
-
2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
por: Chong, Pearlie P, et al.
Publicado: (2019) -
475. "The Outcomes and Adverse Effects of COVID-19 Therapies in High-Risk Children"
por: Holschier, Johanna, et al.
Publicado: (2023) -
Posaconazole-Induced Hypertension and Hypokalemia: Mechanistic Evaluation
por: Thompson, George R, et al.
Publicado: (2017) -
2904. Use Of Biofire® Joint Infection Filmarray for the Microbiological Diagnosis of Acute Hematogenous Septic Arthritis in Children
por: Boast, Alison, et al.
Publicado: (2023) -
2571. Higher Rates of Hospitalization and Infection-Related Hospitalization Among HIV-Exposed Uninfected Infants Compared with HIV Unexposed Uninfected Infants in the United States
por: Labuda, Sarah M, et al.
Publicado: (2018)